Compare Abbott Laboratories (ABT) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Utilities Select Sector SPDR Fund — how do they compare? Abbott Laboratories trades at $95.61 (market cap $166.94B), while Utilities Select Sector SPDR Fund trades at $45.59. The key difference: Abbott Laboratories pays a 2.63% dividend while Utilities Select Sector SPDR Fund pays none, and Utilities Select Sector SPDR Fund is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | XLU | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | — |
52-Week High | $136.62 | $47.73 |
52-Week Low | $82.57 | $40.57 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
XLU trades at $45.30, down 1.01% today, with a bullish technical signal supported by moving averages. The ETF provides pure exposure to US utilities, benefiting from AI-driven power demand growth. Recent news highlights utilities' role in powering AI data centers, with top holdings securing long-term clean energy agreements. Technical indicators show neutral oscillators but bullish ADX signals, with key support at $44-$45 and resistance at $46.
The outlook for XLU is positive due to structural demand growth from AI infrastructure, though valuation metrics are unavailable. Risks include interest rate sensitivity and regulatory uncertainty. Analyst sentiment is mixed, with utilities transitioning from bond proxies to growth plays amid rising power needs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
